Type 2 diabetes spreads due to changes in lifestyle and mainly occurs in overweight and aged people worldwide
Frequent and prolonged vomiting (more than two weeks) Stomach paralysis (gastroparesis) the most common injury in the federal litigation Intestinal blockage (paralytic ileus) Bowel obstruction Gallbladder disease gallstones and gallbladder inflammation Pancreatitis Kidney damage, including acute kidney injury (AKI) Thyroid cancer and thyroid tumors Sudden vision loss (NAION) now its own federal MDL Injuries from compounded or counterfeit semaglutide and tirzepatide The GLP-1 litigation landscape changes regularly new MDLs open, label warnings are added, and filing deadlines shift
Anyone seeking a natural boost to their metabolism and energy levels
The upfront costs of GLP-1s are an ongoing concern for both public and private payers, and some employers and state Medicaid programs are now restricting coverage, despite recognizing their effectiveness at treating obesity
Serious health issues such as pancreatitis, thyroid cancer, pancreas cancer, and gallstones have also been associated with both compounded and FDA approved versions of semaglutide
Biochemical Pharmacology, 2011